Detalhe da pesquisa
1.
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Br J Cancer
; 130(5): 777-787, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191609
2.
Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers.
Cancer Med
; 8(3): 882-889, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30690930